Publicaciones en colaboración con investigadores/as de Hospital Duran i Reynals (23)

2024

  1. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification

    British Journal of Haematology, Vol. 204, Núm. 4, pp. 1529-1535

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

    HemaSphere, Vol. 7, Núm. 10, pp. E961

2022

  1. SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis

    Clinical and Translational Oncology, Vol. 24, Núm. 2, pp. 215-226

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

    Experimental Hematology and Oncology

  3. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  4. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  5. Systematic review of educational interventions to improve contouring in radiotherapy

    Radiotherapy and Oncology, Vol. 144, pp. 86-92

  6. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538

2018

  1. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

    Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584

  2. Preliminary study of the effect of stereotactic body radiotherapy (SBRT) on the immune system in lung cancer patients unfit for surgery: Immunophenotyping analysis

    International Journal of Molecular Sciences, Vol. 19, Núm. 12

2017

  1. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1337-1349

2016

  1. Spine Instability Neoplastic Score: agreement across different medical and surgical specialties

    Spine Journal, Vol. 16, Núm. 5, pp. 591-599

2015

  1. Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: Is it an underestimated phenomenon A radiation oncologist's perspective

    European Journal of Clinical Nutrition, Vol. 69, Núm. 7, pp. 757-760

2011

  1. Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response

    Current Medical Research and Opinion, Vol. 27, Núm. 5, pp. 951-960

2009

  1. CFTR mutations in cystic fibrosis patients from Murcia region (southeastern Spain): Implications for genetic testing

    Clinical Genetics

  2. Screening for epidermal growth factor receptor mutations in lung cancer

    New England Journal of Medicine, Vol. 361, Núm. 10, pp. 958-967

2008

  1. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain

    Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869

2003

  1. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

    Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151